Evidence map›Paper›PMID 41976198›Full record

ArticleMolecules (Basel, Switzerland)2026

Enhanced Interfacial Plasma Degradation of Per- and Polyfluoroalkyl Substances (PFAS) via Ultrasonically Generated Microdroplets.

Ao Chen, Haoyu Yuan, Zhengtong Qiu, Chaonan Mu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ao ChenState Key Laboratory of Marine Resource Utilization in South China Sea, School of Marine Sciences, Hainan University, Haikou 570228, China.
Haoyu YuanState Key Laboratory of Marine Resource Utilization in South China Sea, School of Marine Sciences, Hainan University, Haikou 570228, China.
Zhengtong QiuState Key Laboratory of Marine Resource Utilization in South China Sea, School of Marine Sciences, Hainan University, Haikou 570228, China.
Chaonan MuState Key Laboratory of Marine Resource Utilization in South China Sea, School of Marine Sciences, Hainan University, Haikou 570228, China.ORCID 0009-0003-5502-8879

Funding

Hainan Provincial Natural Science Foundation of China No. 225MS005Hainan University Research Start-up Fund No. kyqd(XJ)2300005713National Natural Science Foundation of China No. 22204041
6 · The paper itself

Abstract

The exceptional stability of C-F bonds renders PFAS highly persistent in aqueous environments, posing significant challenges for conventional treatment technologies. While plasma-based technologies show promise, their efficiency is often limited by poor gas-liquid mass transfer in bulk liquid. Here, an in-house constructed ultrasonic atomization-dielectric barrier discharge (UEN-DBD) system was developed to promote PFAS degradation under non-thermal plasma conditions. Ultrasonic atomization generated microdroplets, which promoted PFAS enrichment at the surface of microdroplets and facilitate interactions with plasma-generated reactive species. Using perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) as model compounds, degradation behavior was evaluated over an initial concentration range of 0.01-1.0 ppm. At 0.01 ppm, degradation efficiencies of 96.06% for PFOA and 94.86% for PFOS were achieved within 5 min. Electron paramagnetic resonance (EPR) spectroscopy confirmed the formation of oxidative radicals (·OH) and suggested a mixed redox environment involving reactive species, potentially including superoxide (O

Indexed as

interfacial degradationmicrodroplet interfacesnon-thermal plasmaPFASultrasonic atomization

Identifiers

PMID41976198
PMCPMC13075150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.